Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

M. Pamukçu; G. Mutlu; G. Yakupoğlu; G. Süleymanlar; 0. Yeğin

EN

Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Abstract

We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults. Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule. One month after the third dose, seroconversion rate was 100% and all subjects had antibodies to hepatitis B surface antigen tilers in excess of 10IU / L. No serious adverse reactions attributable to the vaccine, were observed.

Keywords

Hepatitis B,prevention and control

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

M. Pamukçu This is me

G. Mutlu This is me

G. Yakupoğlu This is me

G. Süleymanlar This is me

0. Yeğin This is me

Publication Date

January 1, 1991

Submission Date

November 1, 1990

Acceptance Date

-

Published in Issue

Year 1991 Volume: 4 Number: 1

IZ

https://izlik.org/JA26HG95NJ

Cite

RIS / Bibtex

APA

Pamukçu, M., Mutlu, G., Yakupoğlu, G., Süleymanlar, G., & Yeğin, 0. (1991). Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal, 4(1), 31-35. https://izlik.org/JA26HG95NJ

AMA

1.Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J. 1991;4(1):31-35. https://izlik.org/JA26HG95NJ

Chicago

Pamukçu, M., G. Mutlu, G. Yakupoğlu, G. Süleymanlar, and 0. Yeğin. 1991. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal 4 (1): 31-35. https://izlik.org/JA26HG95NJ.

EndNote

Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. (January 1, 1991) Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal 4 1 31–35.

IEEE

[1]M. Pamukçu, G. Mutlu, G. Yakupoğlu, G. Süleymanlar, and 0. Yeğin, “Immunogenicity of a recombinant yeast-derived hepatitis b vaccine”, Marmara Med J, vol. 4, no. 1, pp. 31–35, Jan. 1991, [Online]. Available: https://izlik.org/JA26HG95NJ

ISNAD

Pamukçu, M. - Mutlu, G. - Yakupoğlu, G. - Süleymanlar, G. - Yeğin, 0. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal 4/1 (January 1, 1991): 31-35. https://izlik.org/JA26HG95NJ.

JAMA

1.Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J. 1991;4:31–35.

MLA

Pamukçu, M., et al. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal, vol. 4, no. 1, Jan. 1991, pp. 31-35, https://izlik.org/JA26HG95NJ.

Vancouver

1.M. Pamukçu, G. Mutlu, G. Yakupoğlu, G. Süleymanlar, 0. Yeğin. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J [Internet]. 1991 Jan. 1;4(1):31-5. Available from: https://izlik.org/JA26HG95NJ